Dysgerminoma: diagnostic impasse
DOI:
https://doi.org/10.18203/2349-2902.isj20204700Keywords:
Dysgerminoma, GIST, Malignant ovarian tumour, Huge abdominal massAbstract
Dysgerminoma is a rare malignant ovarian tumour in women of reproductive age group, featuring lower abdominal pain and abdominal mass with elevated tumour markers. The tumour grows rapidly and diagnosed at an earlier stage. We present a short-statured 20 years girl with intermittent abdominal pain and distention for 4 months, on examination huge abdominal mass of size 20x15 cm, firm in consistency was palpable, lower limit not ascertained. Routine blood investigations normal, thyroid function test showed hypothyroidism. A plain abdominal radiograph shows a large homogenous mass fitting mid part of abdomen with displaced bowel loop. Contrast-enhanced computed tomography abdomen and pelvis show up 20x18.5x9.5 cm well defined heterogeneous mass, with areas of necrosis suggesting mesenchymal tumour or germ cell tumour. CA 125, alpha-fetoprotein, lactate dehydrogenase, beta human chorionic gonadotropin were raised. Magnetic resonance imaging abdomen and pelvis show 10x16x17cm hetero intense lesion, bilateral ovary normal. After tumour board discussion image-guided biopsy was done, suggestive of epithelioid gastrointestinal stromal tumour. Laparotomy displayed a large mass 22x16x10 cm arising from left ovary, no enlarged lymph node, completed with left salpingo-oophorectomy. Histopathology examination and immunohistochemistry definitive of dysgerminoma. In this clinical scenario, we narrate the importance of clinical examination and increased dependence on imaging modalities in diagnosing the patient. The treatment is based on the international federation of gynaecology and obstetrics staging with surgical treatment, adjuvant chemotherapy and radiotherapy.
References
Kamal N, Khan U, Mirza S, Mazoun K, Mirza F, Jundi M. Ovarian dysgerminoma with normal serum tumour markers presenting in a child with precocious puberty. J Cancer Res Ther. 2015;11(3):661.
Michael K, Wampler K, Underwood J, Hansen C. Ovarian dysgerminoma. J Diagn Med Sonogr. 2015;31(5):327-30.
Sato Y, Hayashi T, Yamamoto H, Niina I, Kuroki N, Iwamura T, et al. Late recurrence in ovarian dysgerminoma presenting as a primary retroperitoneal tumor: a case report and review of the literature. Case Rep Pathol. 2020;2020:1-5.
Gershenson D. Update on malignant ovarian germ cell tumors. Cancer. 1993;71(S4):1581-90.
Kanagal D. Ovarian gonadoblastoma with dysgerminoma in a young girl with 46XX Karyotype: a case report. J Clin Diagn Res. 2013;7(9)2021-2.
Gupta M. An incidental finding of bilateral dysgerminoma during cesarean section: dilemmas in management. J Clin Diagn Res. 2016;10(8):QD4-5.
Lazebnik N, Balog A, Bennett S, Redline R, Liu J. Ovarian dysgerminoma. J Med Ultrasound. 2009;28(10):1409-15.
Sever M, Jones T, Roth L, Karim F, Zheng W, Michael H, et al. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Mod Pathol. 2005;18(11):1411-6.
McIntyre A, Summersgill B, Grygalewicz B, Gillis A, Stoop J, Van Gurp R, et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res. 2005;65(18):8085-9.
Mangili G, Sigismondi C, Lorusso D, Cormio G, Scollo P, Viganò R, et al. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. Gynecol Oncol. 2011;121(2):280-4.
Kumar S, Shah J, Bryant C, Imudia A, Cote M, Ali-fehmi R, et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol. 2008;110(2):125-32.
